Oncology News

Nineteen days ago, Karyn Edwards of Wolcott reported that her little girl Kylie is in remission.

Adding the cancer drug dasatinib to standard hormone therapy may slow the progression of advanced breast cancer, a preliminary study suggests.

While women fighting breast cancer have the powerful pink ribbon on their side and men promote prostate health with fashionable facial hair , not all cancers garner the same level of public interest.

Genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and valuable guidance on treatment options, according to recent research presented this year... - Genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and valuable guidance about ... (more)

One drug attacks tumor cells directly, the other treats the immune system by taking the brakes off T cell response.

A 26-year-old woman disfigured by a tumor has received a new face in Poland's second such transplant.

The report stresses, however, that recent budget cuts and years-long flat funding can only delay efforts to translate research into effective treatments for millions of individuals with cancer.

Scancell, a company which grew out of research carried out by a team at the University of Nottingham, reports that results from trials of a vaccine which targets a serious skin cancer have exceeded their highest expectations.

Women with aggressive breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a slightly improved chance of staying cancer-free, researchers say.

After chemotherapy, surgery and radiation to treat the original tumor might not benefit women with advanced breast cancer, a new study shows.

Leading provider of comprehensive, integrated cancer care is the newest member of a growing network of world-renowned cancer centers and groups By participating in the Strategic Alliance Partnership program, 21st Century Oncology will be able to leverage OncLive's extensive portfolio of print and online channels to raise awareness of the ... (more)

Gaithersburg-based MedImmune and Johns Hopkins University have entered into a five-year, $6.5 million research partnership, the company announced Wednesday.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, in conjunction with Barnabas Health, successfully enrolled the first patient in a groundbreaking breast cancer research trial.

Expected and actual patient enrollment differs by an average 7.1% among the Phase 3 oncology trials examined in a recent Cutting Edge Information study.

With husband Bill Klein by her side, Jen Arnold, star of TLC's The Little Couple is opening up about her fight to get well after her shocking cancer diagnosis exclusively with PEOPLE.

Dear Dr. Roach: For several years, when I have had blood drawn it has shown an elevation in the alkaline phosphatase.

Top left - Jan Van Voorst, top right - Mark Goldstein, bottom left - Cecelia Izzo, bottom right - Hyla Dobaj.

We've found an existing account with the given email. To link the social network identity with your site account, please provide the site password for the provided email.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that it will announce its financial and operational results for the second quarter ended October 31, 2013 after the market closes on Thursday, December 12. In connection, ... (more)

ProNai Therapeutics Inc. reported promising new results Sunday from an ongoing Phase II study of its lead drug candidate at the 55th Annual Meeting of the American Society for Hematology in New Orleans, La.